Notify me when Riverbridge Partners Llc files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 186 | $5.93B | +$169M | -$516M | -$347M | NVDA, MSFT, HEI, LOPE, MEDP | 13F-HR | 10/14/2025, 10:26 AM |
| Q2 2025 | 185 | $6.22B | +$237M | -$694M | -$457M | NVDA, MSFT, HEI, LOPE, RBA | 13F-HR | 7/15/2025, 04:31 PM |
| Q1 2025 | 180 | $6.23B | +$61.4M | -$471M | -$409M | LOPE, HEI, NVDA, MSFT, RBA | 13F-HR | 4/21/2025, 03:48 PM |
| Q4 2024 | 179 | $7.33B | +$199M | -$624M | -$425M | NVDA, GLOB, MSFT, LOPE, HEI | 13F-HR | 1/17/2025, 03:30 PM |
| Q3 2024 | 182 | $7.49B | +$214M | -$536M | -$322M | NVDA, MSFT, GLOB, HEI, RBA | 13F-HR | 10/15/2024, 02:16 PM |
| Q2 2024 | 178 | $7.36B | +$424M | -$545M | -$121M | MSFT, NVDA, GLOB, LOPE, HEI | 13F-HR | 7/17/2024, 02:14 PM |
| Q1 2024 | 174 | $8.2B | +$172M | -$481M | -$309M | GLOB, MSFT, RBA, MEDP, NVDA | 13F-HR | 4/26/2024, 04:21 PM |
| Q4 2023 | 202 | $8B | +$201M | -$326M | -$125M | GLOB, FIVE, LOPE, RBA, MSFT | Restatement | 2/15/2024, 02:47 PM |
| Q3 2023 | 192 | $7.33B | +$268M | -$424M | -$156M | GLOB, RBA, FIVE, LOPE, WK | Restatement | 2/15/2024, 02:55 PM |
| Q2 2023 | 192 | $7.93B | +$779M | -$501M | +$277M | FIVE, GLOB, RBA, CSGP, MSFT | 13F-HR | 7/25/2023, 01:18 PM |
| Q1 2023 | 189 | $7.13B | +$234M | -$463M | -$229M | FIVE, RBA, GLOB, LOPE, WK | 13F-HR | 4/21/2023, 01:45 PM |
| Q4 2022 | 195 | $6.66B | +$190M | -$316M | -$126M | FIVE, RBA, GLOB, LOPE, CSGP | 13F-HR | 1/11/2023, 01:04 PM |
| Q3 2022 | 194 | $6.73B | +$827M | -$226M | +$602M | GLOB, RBA, FIVE, PCTY, CSGP | 13F-HR | 10/26/2022, 10:27 AM |
| Q2 2022 | 195 | $6.25B | $0 | $0 | RBA, GLOB, LOPE, MSFT, FIVE | New Holdings | 8/29/2022, 03:02 PM | |
| Q2 2022 | 199 | $6.25B | +$271M | -$989M | -$718M | RBA, GLOB, LOPE, MSFT, FIVE | 13F-HR | 7/11/2022, 03:47 PM |
| Q1 2022 | 161 | $8.85B | +$658M | -$599M | +$58.9M | GLOB, AMED, LOPE, RBA, FIVE | 13F-HR | 4/20/2022, 01:55 PM |
| Q4 2021 | 168 | $10.1B | +$584M | -$519M | +$64.8M | GLOB, FIVE, WST, RBA, MSFT | 13F-HR | 1/14/2022, 05:01 PM |
| Q3 2021 | 156 | $9.97B | +$419M | -$356M | +$62.1M | GLOB, RBA, FIVE, WST, LOPE | 13F-HR | 10/26/2021, 11:22 AM |
| Q2 2021 | 157 | $9.85B | +$1.12B | -$373M | +$746M | GLOB, FIVE, RBA, LOPE, AMED | 13F-HR | 7/26/2021, 01:43 PM |
| Q1 2021 | 153 | $8.78B | +$632M | -$714M | -$82M | GLOB, LOPE, FIVE, RBA, AMED | 13F-HR | 4/21/2021, 04:38 PM |
| Q4 2020 | 152 | $9.05B | +$684M | -$135M | +$549M | GLOB, BL, FIVE, RBA, CSGP | 13F-HR | 1/22/2021, 04:00 PM |
| Q3 2020 | 148 | $7.17B | +$568M | -$312M | +$257M | GLOB, RBA, FIVE, PRLB, CSGP | 13F-HR | 10/8/2020, 01:15 PM |
| Q2 2020 | 148 | $6.37B | +$324M | -$247M | +$77.1M | GLOB, PRLB, CSGP, LOPE, BL | 13F-HR | 7/8/2020, 11:53 AM |
| Q1 2020 | 137 | $4.78B | +$200M | -$258M | -$57.9M | CHE, CSGP, TDOC, LOPE, GLOB | 13F-HR | 4/13/2020, 03:43 PM |
| Q4 2019 | 138 | $5.57B | +$183M | -$269M | -$86M | LOPE, CHE, PRLB, CSGP, RBA | 13F-HR | 1/14/2020, 03:59 PM |
| Q3 2019 | 134 | $5.28B | +$181M | -$98.9M | +$82.2M | PRLB, CHE, CSGP, RBA, FIVE | 13F-HR | 10/11/2019, 04:03 PM |
| Q2 2019 | 136 | $5.29B | +$420M | -$564M | -$144M | PRLB, CSGP, GLOB, LOPE, RBA | 13F-HR | 7/10/2019, 03:58 PM |
| Q1 2019 | 132 | $5.15B | +$161M | -$560M | -$400M | ULTI, PRLB, HEI, RBA, LOPE | 13F-HR | 4/4/2019, 02:56 PM |
| Q4 2018 | 131 | $4.8B | +$278M | -$461M | -$183M | PRLB, RBA, NATI, HCSG, CHE | 13F-HR | 1/14/2019, 11:11 AM |
| Q3 2018 | 131 | $5.98B | +$223M | -$421M | -$197M | PRLB, ULTI, RBA, HEI, CHE | 13F-HR | 10/3/2018, 12:17 PM |
| Q2 2018 | 128 | $5.55B | +$252M | -$403M | -$150M | PRLB, FIVE, RBA, CHE, LOPE | 13F-HR | 7/3/2018, 10:22 AM |
| Q1 2018 | 133 | $5.48B | +$283M | -$208M | +$74.8M | LOPE, PRLB, NATI, ULTI, HEI | 13F-HR | 4/3/2018, 11:29 AM |
| Q4 2017 | 138 | $5.17B | +$159M | -$360M | -$201M | LOPE, PRLB, RBA, ULTI, HCSG | 13F-HR | 1/24/2018, 02:32 PM |
| Q3 2017 | 139 | $5.08B | +$214M | -$437M | -$223M | LOPE, CSGP, HCSG, PRLB, NATI | 13F-HR | 11/1/2017, 12:23 PM |
| Q2 2017 | 139 | $5.23B | +$382M | -$456M | -$73.5M | NATI, LOPE, CSGP, ULTI, ATHN | 13F-HR | 7/24/2017, 09:26 AM |
| Q1 2017 | 135 | $4.98B | +$128M | -$315M | -$187M | LOPE, NATI, ULTI, CSGP, CHE | 13F-HR | 4/25/2017, 10:01 AM |
| Q4 2016 | 133 | $4.76B | +$385M | -$633M | -$248M | NATI, LOPE, ULTI, GNTX, CSGP | 13F-HR | 1/20/2017, 12:47 PM |
| Q3 2016 | 131 | $5B | +$246M | -$359M | -$113M | CPHD, ULTI, CSGP, NATI, RBA | 13F-HR | 10/24/2016, 12:33 PM |
| Q2 2016 | 133 | $4.82B | +$173M | -$362M | -$189M | ULTI, CSGP, RBA, HCSG, ATHN | 13F-HR | 8/1/2016, 04:53 PM |
| Q1 2016 | 135 | $4.8B | +$247M | -$237M | +$10.8M | ULTI, CSGP, PRLB, LOPE, ATHN | 13F-HR | 4/27/2016, 02:41 PM |
| Q4 2015 | 138 | $4.87B | +$318M | -$476M | -$158M | ULTI, CSGP, ATHN, BECN, CHE | 13F-HR | 1/28/2016, 05:20 PM |
| Q3 2015 | 135 | $4.85B | +$337M | -$424M | -$86.8M | ULTI, CPHD, ATHN, CSGP, MD | 13F-HR | 10/23/2015, 04:00 PM |
| Q2 2015 | 134 | $5.3B | +$228M | -$531M | -$304M | CPHD, ULTI, TRAK, CSGP, ROL | 13F-HR | 7/20/2015, 12:06 PM |
| Q1 2015 | 131 | $5.56B | +$394M | -$197M | +$197M | CPHD, ULTI, CSGP, NATI, GNTX | 13F-HR | 4/23/2015, 09:39 AM |
| Q4 2014 | 129 | $5.38B | +$235M | -$472M | -$237M | CPHD, ULTI, RBA, CSGP, ATHN | 13F-HR | 1/20/2015, 12:43 PM |
| Q3 2014 | 128 | $5.13B | +$377M | -$711M | -$335M | CPHD, ULTI, NATI, ATHN, RBA | 13F-HR | 11/5/2014, 12:31 PM |
| Q2 2014 | 130 | $5.74B | +$413M | -$60.5M | +$352M | CPHD, ULTI, NATI, PRAA, RBA | 13F-HR | 7/31/2014, 11:47 AM |
| Q1 2014 | 128 | $5.53B | +$250M | -$178M | +$71.9M | CPHD, ULTI, PRAA, RBA, MD | 13F-HR | 5/9/2014, 12:10 PM |
| Q4 2013 | 126 | $5.52B | $0 | $0 | CPHD, ULTI, NATI, CSGP, ATHN | 13F-HR | 2/10/2014, 10:41 AM |